Form 4: ANI Pharmaceuticals SVP, Chief HR Officer Reports Stock Transaction
SEC Form 4 Filing
Krista Davis, SVP, Chief HR Officer of ANI Pharmaceuticals, reports the disposition of 1,173 shares of common stock to cover tax obligations related to vesting restricted stock.
Summary
- On February 29, 2024, Krista Davis, SVP, Chief HR Officer of ANI Pharmaceuticals, disposed of 1,173 shares of common stock.
- The shares were withheld for tax purposes in connection with the vesting of 3,039 shares of restricted stock.
- The transaction was exempt under Rule 16(b)-3.
- The price per share was $67.67.
- Following the transaction, Davis beneficially owns 51,545 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't indicate a change in the officer's overall confidence in the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. This is a routine transaction related to tax obligations on vested equity.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of stock transaction (disposal of shares) |
| 03/01/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.